Skin cancer risk among patients with type 2 diabetes treated with hydrochlorothiazide
Completed
- Conditions
- Type 2 diabetes, hypertension, skin cancer
- Registration Number
- NL-OMON28736
- Lead Sponsor
- university medical center groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 71648
Inclusion Criteria
Type 2 diabetes patients treated in the primary care
Exclusion Criteria
Type 2 diabtes patientes who had a history of skin cancer before cohort entry
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hazard ratio of skin cancer risk exposing to hydrochlorothiazide compared with no expose to hydrochlorothiazide
- Secondary Outcome Measures
Name Time Method Existence of exposure-time-response relationship